Absci (ABSI) and Owkin announced a partnership bringing together two leading AI platforms to rapidly discover and design ...

Francis deSouza is Google Cloud’s new chief operating officer. He co-founded AI research startup Synth Labs last year after ...

Investors sell off AMD shares despite the company's pivot to life sciences AI, following a rating downgrade by HSBC that followed a six-month decline in the stock price.

We recently published a list of 13 AI News and Ratings You Probably Missed. In this article, we are going to take a look at ...

S&P 500 giant Exxon Mobil went against the industry grain and boosted its capital spending outlook. Exxon said it would hold ...

The semiconductor maker has underperformed peers amid a contrast between the haves and the have-nots in the chip sector, the bank says.

Absci Corporation (NASDAQ: ABSI), a data-first generative AI drug creation company, and Owkin, a TechBio that uses agentic AI to unlock complex targets for drug discovery, development, and diagnostics ...

Nurses and other health care workers in Michigan want increased wages, better benefits, and improved working conditions. The five-day strike will start Jan. 20. More industry news is about Blue Shield ...

The stake comes alongside an agreement for Vancouver, Washington-based Absci to use AMD chips and software to power its drug ...

Novo Nordisk on Wednesday announced an expanded deal with healthtech firm Valo Health to use AI to fuel drug discovery.

In a strategic move to expand its footprint in the healthcare sector, Advanced Micro Devices (AMD) has announced a $20 ...

Absci will use AMD’s $20 million investment to enhance its AI models. In parallel, the companies will collaborate to develop ...